Healthcare Sector

NVO

Market Tracker

$85.17
-2.48
(-2.83%)
6:15 pm
Next Earnings: (est.) n/a
  • NVO (Selected)

    Novo Nordisk A/S
  • NVOS

    Novo Integrated Sciences, Inc.

NVO Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

NVO Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

NVO Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

NVO Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

NVO Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

NVO Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/10/2025 PUT $84.00 5,424 +4,655 +605.33%
01/10/2025 PUT $85.00 1,586 +1,027 +183.72%
01/10/2025 PUT $88.00 2,173 +771 +54.99%
03/21/2025 PUT $85.00 3,015 +615 +25.63%
02/21/2025 PUT $80.00 1,175 +343 +41.23%
01/16/2026 PUT $77.50 434 +300 +223.88%
03/21/2025 CALL $105.00 2,276 -54 -2.32%
01/10/2025 CALL $90.00 2,460 -63 -2.50%
01/17/2025 CALL $100.00 4,598 -67 -1.44%
01/17/2025 PUT $95.00 10,932 -113 -1.02%
01/17/2025 PUT $82.50 1,182 -116 -8.94%
01/17/2025 CALL $90.00 2,689 -285 -9.58%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

NVO Major Holders

Name Pct Held Shares Total
Harbor Capital Appreciation Fund 0.18% 3.11M 481.53M
Washington Mutual Investors Fund 0.09% 1.51M 234.45M
Vanguard U.S. Growth Fund 0.07% 1.27M 196.47M
Loomis Sayles Growth Fund 0.07% 1.18M 183.13M
Fidelity Blue Chip Growth Fund 0.07% 1.13M 175.35M
Amana Mutual Funds Trust-Growth Fund 0.06% 1M 155.09M
PGIM Jennison Growth Fd 0.05% 828.11k 128.15M
Blackrock Equity Dividend Fund 0.04% 712k 110.18M
New Perspective Fund Inc 0.04% 691.44k 107M
Price (T.Rowe) International Stock Fund 0.04% 674k 104.3M

NVO News

  • Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug

    01/06 09:00 am

    Benzinga

    Read more
  • Is Novo Nordisk an Undervalued Stock to Buy Now?

    01/06 05:30 am

    The Motley Fool

    Read more
  • What's Going on With Novo Nordisk Stock?

    01/05 06:23 am

    The Motley Fool

    Read more
  • Better Buy: Novo Nordisk vs. AstraZeneca

    01/04 06:42 am

    The Motley Fool

    Read more
  • 4 Top Stocks to Buy in January

    01/02 11:30 am

    The Motley Fool

    Read more
  • Should You Buy the Dip in Novo Nordisk Stock Right Now?

    01/02 09:30 am

    The Motley Fool

    Read more
  • Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better

    01/02 06:04 am

    Investing.com

    Read more
  • Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business

    12/31 09:30 am

    GlobeNewswire Inc.

    Read more
  • 3 Stocks That Could Be Monster Winners in 2025

    12/29 07:47 am

    The Motley Fool

    Read more
  • Billionaire Philippe Laffont Is Selling Artificial Intelligence Champion Nvidia and Piling Into These Two Industry Leaders

    12/29 06:39 am

    The Motley Fool

    Read more
  • Is Eli Lilly Stock a Buy?

    12/29 05:35 am

    The Motley Fool

    Read more
  • 10 Top Growth Stocks for 2025

    12/28 12:03 pm

    The Motley Fool

    Read more
  • 2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades

    12/28 07:05 am

    The Motley Fool

    Read more
  • Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.

    12/26 11:15 am

    The Motley Fool

    Read more
  • Global Peptide Therapeutics Market to Skyrocket: Estimated Growth at a CAGR of 10.8% to Reach USD 117.4 Billion by 2034: FMI

    12/26 09:30 am

    GlobeNewswire Inc.

    Read more
  • Better Buy: Eli Lilly or Novo Nordisk?

    12/23 10:30 am

    The Motley Fool

    Read more
  • Novo Nordisk, Super Micro Computer And Arm Are Among Top Large Cap Losers Last Week (December 16-20): Are The Others In Your Portfolio?

    12/22 11:38 am

    Benzinga

    Read more
  • Is Merck the Next Big Weight-Loss Stock?

    12/22 07:45 am

    The Motley Fool

    Read more
  • 3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

    12/21 07:48 am

    The Motley Fool

    Read more
  • Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

    12/21 05:55 am

    The Motley Fool

    Read more
  • What's Going On With Amgen Stock On Friday?

    12/20 03:40 pm

    Benzinga

    Read more
  • Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial

    12/20 06:41 am

    GlobeNewswire Inc.

    Read more
  • This Is Huge News for Eli Lilly Investors

    12/19 05:44 am

    The Motley Fool

    Read more
  • 5 Top European Stocks to Buy Before 2025

    12/16 11:48 am

    The Motley Fool

    Read more
  • Novo Nordisk A/S - share repurchase programme

    12/16 08:52 am

    GlobeNewswire Inc.

    Read more
  • Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

    12/16 02:29 am

    GlobeNewswire Inc.

    Read more
  • 2 Brand-New Reasons to Buy Eli Lilly Stock Right Now, and 2 Reasons to Be Cautious

    12/15 03:05 pm

    The Motley Fool

    Read more
  • Telehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound

    12/12 10:38 am

    Benzinga

    Read more
  • Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street

    12/06 06:47 am

    The Motley Fool

    Read more
  • Eli Lilly: Breakthrough Trial Results Set Stage for Market Growth, Stock Gains

    12/05 06:32 am

    Investing.com

    Read more
  • Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?

    11/30 07:20 am

    The Motley Fool

    Read more
  • Is Novo Nordisk Stock a Buy?

    11/29 06:35 am

    The Motley Fool

    Read more
  • Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?

    11/29 05:28 am

    The Motley Fool

    Read more
  • Is Novo Nordisk Stock a Buy Right Now?

    11/20 07:10 am

    The Motley Fool

    Read more
  • 3 Growth Stocks You Can Buy Right Now Without Any Hesitation

    11/18 07:03 am

    The Motley Fool

    Read more
  • 3 Things You Need to Know if You Buy Viking Therapeutics Today

    11/18 05:45 am

    The Motley Fool

    Read more
  • 2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious

    11/16 09:45 am

    The Motley Fool

    Read more
  • Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.

    11/16 06:30 am

    The Motley Fool

    Read more
  • Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

    11/15 05:05 am

    The Motley Fool

    Read more
  • Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

    11/14 08:15 am

    The Motley Fool

    Read more
  • 1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More

    11/10 10:30 am

    The Motley Fool

    Read more
  • Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?

    11/10 06:45 am

    The Motley Fool

    Read more
  • Is Viking Therapeutics a Buy on the Dip?

    11/10 06:15 am

    The Motley Fool

    Read more
  • Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag

    11/07 11:15 am

    The Motley Fool

    Read more
  • Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024

    11/06 02:41 am

    GlobeNewswire Inc.

    Read more
  • Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024

    11/06 02:30 am

    GlobeNewswire Inc.

    Read more
  • Prediabetes Market to hit USD 360.6 million by 2032, says Global Market Insights Inc.

    11/05 07:00 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: